Frankenius Equity AB

Holdings History for TriSalus Life Sciences, Inc. - Common stock, $0.0001 par value (TLSI)

Symbol: TLSI on Nasdaq
Investment type: Equity / Common stock, $0.0001 par value
Latest Disclosed Shares Owned: 6,989,748 shares
Security Ownership %: 14%

Frankenius Equity AB ownership in TriSalus Life Sciences, Inc. Common stock, $0.0001 par value (TLSI)

04 Aug 2025 - Frankenius Equity AB has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,989,748 shares of TriSalus Life Sciences, Inc. Common stock, $0.0001 par value (TLSI). This represents 14% ownership of the company. In their previous filing dated 02 May 2025, Frankenius Equity AB had reported owning 6,732,516 shares, indicating an increase of +3.8%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Frankenius Equity AB	14%	-31%	$34,179,868	6,989,748	+257,232	+3.8%	$4.89	13D/A	31 Jul 2025	04 Aug 2025, 07:33
Frankenius Equity AB	20%	-1.9%	$38,509,992	6,732,516	+243,797	+3.8%	$5.72	13D/A	30 Apr 2025	02 May 2025, 16:17
Frankenius Equity AB	21%		$37,115,473	6,488,719			$5.72	13D/A	17 Dec 2024	19 Dec 2024, 16:12